Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-009-2 | CAS number: 7783-56-4
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- not specified
- Adequacy of study:
- other information
- Study period:
- 1959
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- RTECS, ChemIDplus
Data source
Reference
- Reference Type:
- other: database (RTECS, ChemIDplus)
- Title:
- not reported
- Author:
- Osaka Shiritsu Daigaku Igaku Zasshi.
- Year:
- 1 959
- Bibliographic source:
- Journal of the Osaka City Medical Center. Vol. 8, Pg. 817, 1959.
Materials and methods
- GLP compliance:
- not specified
- Test type:
- other: not specified
Test material
- Reference substance name:
- Antimony trifluoride
- EC Number:
- 232-009-2
- EC Name:
- Antimony trifluoride
- Cas Number:
- 7783-56-4
- Molecular formula:
- F3Sb
- IUPAC Name:
- antimony trifluoride
- Test material form:
- not specified
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- not specified
- Sex:
- not specified
Administration / exposure
- Route of administration:
- oral: unspecified
- Doses:
- not specified
- No. of animals per sex per dose:
- not specified
Results and discussion
Effect levels
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 804 mg/kg bw
- Mortality:
- not specified
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Executive summary:
RTECS and ChemIDplus database entry: mouse LD50 oral 804 mg/kg
Source: Osaka Shiritsu Daigaku Igaku Zasshi.Journal of the Osaka City Medical Center.Vol. 8, Pg. 817, 1959
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
